Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

Blood. 2020 Apr 2;135(14):1185-1188. doi: 10.1182/blood.2019004001.

¹ Laboratory of Myeloid Malignancies, Hematology Branch, and.
² Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
³ Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; and.
⁴ DNA Sequencing and Genomics Core, Office of the Scientific Director, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Abstract

There is a Blood Commentary on this article in this issue.